XENEXenon Pharmaceuticals Inc.vs its industry peers
A metric-by-metric comparison of Xenon Pharmaceuticals Inc. against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XENE본 종목 | $6.1B#7 | — | 4.5x#2 | 808.0x#6 | — | -47.6%#7 | -4974.3%#7 | -25.9%#6 | -45.6%#5 | — | — | — |
| VRTX | $121.1B#3 | 28.3x#5 | 6.3x#3 | 10.1x#4 | 8.9%#4 | 838.1%#2 | 34.8%#2 | 20.4%#4 | 25.4%#1 | — | 4.4%#5 | — |
| GILD | $161.6B#2 | 17.7x#1 | 6.9x#4 | 5.5x#1 | 2.4%#5 | 1672.9%#1 | 34.0%#3 | 36.2%#2 | 21.6%#2 | — | 18.8%#4 | 2.5%#1 |
| AMGN | $207.9B#1 | 26.8x#4 | 22.6x#5 | 5.7x#2 | 10.0%#3 | 88.5%#3 | 24.7%#5 | 83.9%#1 | 15.3%#3 | — | 33.8%#2 | 2.5%#2 |
| REGN | — | 18.9x#2 | — | — | 1.0%#6 | 2.1%#5 | 24.9%#4 | 14.2%#5 | 9.4%#4 | — | 39.9%#1 | — |
| ARGX | $52.8B#4 | — | — | — | — | — | — | — | — | — | 27.4%#3 | — |
| INSM | $21.4B#6 | — | 30.3x#6 | 35.2x#5 | 66.7%#1 | -39.7%#6 | -205.6%#6 | -181.1%#7 | -185.1%#6 | 4#1 | -8.1%#6 | — |
| UTHR | $22.0B#5 | 19.1x#3 | 3.7x#1 | 6.9x#3 | 10.6%#2 | 11.7%#4 | 46.9%#1 | 22.6%#3 | — | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice